← back to search

Bonny D. Alvarenga

University of California, San Francisco · US
Area of research
Neurology · Infectious Diseases
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Autoimmune Neurological Disorders and Treatments, Long-Term Effects of COVID-19, and Peripheral Neuropathies and Disorders.
h-index
14
citations
849
works
35
NIH funding
primary concept
email

Recent publications

Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis
Science Advances 2025cited by 8position: middledoi
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
Nature Communications 2025cited by 5position: middledoi
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Science Translational Medicine 2024cited by 24position: middledoi
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency
Science Translational Medicine 2024cited by 21position: middledoi
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
Cell Reports Medicine 2023cited by 53position: middledoi
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
JCI Insight 2022cited by 88position: middledoi
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy
Nature Communications 2022cited by 64position: middledoi
Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms
Cell Reports Medicine 2021cited by 190position: middledoi
Anti–SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms
JAMA Neurology 2021cited by 55position: middledoi
ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens
Cell Reports Medicine 2020cited by 97position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael R. Wilson · University of California, San Francisco3 papers (2020–2022)Joseph L. DeRisi · California Southern University3 papers (2020–2022)Colin R. Zamecnik · University of California, San Francisco3 papers (2020–2022)Jayant V. Rajan · University of California, San Francisco3 papers (2020–2022)Kelsey C. Zorn · Johns Hopkins Medicine2 papers (2020–2021)Rita P. Loudermilk · University of California, San Francisco2 papers (2020–2022)Jessa Alexander · University of California, San Francisco2 papers (2021–2022)Ravi Dandekar · City College of San Francisco2 papers (2021–2022)Sabrina A Mann · University of California, San Francisco1 papers (2020–2020)Samuel J. Pleasure · University of California, San Francisco1 papers (2021–2021)Sharon O. Wietstock · Montefiore Medical Center1 papers (2021–2021)Michel C. Nussenzweig · Rockefeller University1 papers (2020–2020)Sirirak Buarpung · University of California, San Francisco1 papers (2022–2022)Kendall Nash · University of California, San Francisco1 papers (2021–2021)Unurzul Jigmeddagva · University of California, San Francisco1 papers (2022–2022)Thomas Ngo · University of California, San Francisco1 papers (2021–2021)Chloe Gerungan · University of California, San Francisco1 papers (2022–2022)Jill A. Hollenbach · University of California, San Francisco1 papers (2022–2022)Mary Prahl · University of California, San Francisco1 papers (2022–2022)Anne E. Wapniarski · University of California, San Francisco1 papers (2021–2021)